These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
16. Interactions of an Anti-Sickling Drug with Hemoglobin in Red Blood Cells from a Patient with Sickle Cell Anemia. Strader MB; Liang H; Meng F; Harper J; Ostrowski DA; Henry ER; Shet AS; Eaton WA; Thein SL; Alayash AI Bioconjug Chem; 2019 Mar; 30(3):568-571. PubMed ID: 30794381 [TBL] [Abstract][Full Text] [Related]
17. Novel approaches to the treatment of sickle cell disease: the potential of histone deacetylase inhibitors. Okam MM; Ebert BL Expert Rev Hematol; 2012 Jun; 5(3):303-11. PubMed ID: 22780210 [TBL] [Abstract][Full Text] [Related]
18. GBT440 increases haemoglobin oxygen affinity, reduces sickling and prolongs RBC half-life in a murine model of sickle cell disease. Oksenberg D; Dufu K; Patel MP; Chuang C; Li Z; Xu Q; Silva-Garcia A; Zhou C; Hutchaleelaha A; Patskovska L; Patskovsky Y; Almo SC; Sinha U; Metcalf BW; Archer DR Br J Haematol; 2016 Oct; 175(1):141-53. PubMed ID: 27378309 [TBL] [Abstract][Full Text] [Related]
19. Crystallographic analysis of human hemoglobin elucidates the structural basis of the potent and dual antisickling activity of pyridyl derivatives of vanillin. Abdulmalik O; Ghatge MS; Musayev FN; Parikh A; Chen Q; Yang J; Nnamani I; Danso-Danquah R; Eseonu DN; Asakura T; Abraham DJ; Venitz J; Safo MK Acta Crystallogr D Biol Crystallogr; 2011 Nov; 67(Pt 11):920-8. PubMed ID: 22101818 [TBL] [Abstract][Full Text] [Related]
20. Rational Drug Design of Peptide-Based Therapies for Sickle Cell Disease. Olubiyi OO; Olagunju MO; Strodel B Molecules; 2019 Dec; 24(24):. PubMed ID: 31842406 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]